Treatment of Head & Neck Cancer With Chemotherapy and Radiation

NCT00392704 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Bevacizumab
DRUG: Erlotinib
DRUG: Paclitaxel
DRUG: 5-FU
RADIATION: Radiation Therapy

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]